If you suffer from
OA knee pain,
TriVisc® may be a treatment option.
Frequently Asked Questions about TriVisc for the knee
Knee pain caused by osteoarthritis (OA) is suffered by millions of people worldwide1. TriVisc Hyaluronic Acid (HA), may help relieve OA-related knee pain in patients who are unresponsive to non-pharmacologic therapy and simple analgesics.
Talk to your doctor to see if TriVisc 3-injection HA is right for you.
TriVisc is contraindicated in patients with known hypersensitivity to hyaluronate preparations. Intra-articular injections are contraindicated in cases of present infections or skin diseases in the area of the injection site to reduce the potential for developing septic arthritis. The effectiveness of a single treatment cycle of less than 3 injections has not been established. Safety of TriVisc was established in two clinical studies of an identical chemical formulation of TriVisc. In a clinical trial of 306 patients, the frequency of adverse events was 2.9% which was identical to the frequency in the saline-control group. In the first cycle of injections the most commonly reported adverse events in the TriVisc equivalent group included injection site pain (6), allergic reaction (3), arthralgia (2), and bleeding at the injection site (2). In a clinical study involving 513 complete TriVisc equivalent treatment cycles and 487 complete PBS treatment cycles, the frequency of adverse events between the groups was the same and did not increase over the course of the three re-treatment cycles.
1. Mayo Clinic
©2023 ALL RIGHTS RESERVED. ORTHOGENRX IS AN AVANOS COMPANY. TRIVISC IS A REGISTERED TRADEMARK OF ORTHOGENRX
OrthogenRx, Inc. • Doylestown Commerce Center, 2005 S. Easton Road, Suite 207, Doylestown, PA 18901 1-877-517-5445